ロード中...
Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma
INTRODUCTION: Tavokinogene Telseplasmid Electroporation Therapy (TAVO) and Pembrolizumab therapy is being studied in subjects with immune checkpoint inhibitor (ICI) resistant melanoma. TAVO is a novel office-based local therapy shown to be effective in patients with advanced melanoma. The technique...
保存先:
| 出版年: | Int J Surg Case Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7708754/ https://ncbi.nlm.nih.gov/pubmed/33395852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijscr.2020.11.063 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|